Michael W. Dunne's Net Worth

$146 Thousand

Estimate Recalculated Sep 8, 2024 07:30PM EST

Who is Michael W. Dunne?

Michael W. Dunne does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Biota Pharmaceuticals, Inc., Iterum Therapeutics plc, and Durata Therapeutics, Inc..

SEC CIK

Michael W. Dunne's CIK is 0001553593

Past Insider Trading and Trends

2023 was Michael W. Dunne's most active year for acquiring shares with 9 total transactions. Michael W. Dunne's most active month to acquire stocks was the month of April. 2014 was Michael W. Dunne's most active year for disposing of shares, totalling 6 transactions. Michael W. Dunne's most active month to dispose stocks was the month of October. 2013 saw Michael W. Dunne paying a total of $374,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2021 Michael W. Dunne cashed out on 33,143 shares for a total of $57,337.39, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Biota Pharmaceuticals, Inc. (VXRT) Snapshot price: $0.88

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 12
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Sep 21
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.12

Chief Scientific Officer

Michael W. Dunne owns 220,001 units of Ordinary Shares which is worth $246,401.12. From 2018 to 2024 Michael W. Dunne acquired a total of 487,754 shares in Iterum Therapeutics plc at a cost of $157,332.00, Michael also disposed a total of 33,143 shares of Iterum Therapeutics plc equalling to $57,337.39.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+93.40%
106.25K
—
—
220K
Aug 6
Form 4
+28.17%
25K
$1.40
$35,000.00
113.75K
Dec 22
Form 4
+12.70%
10K
$1.84
$18,442.00
88.75K
Dec 18
Form 4
+34.04%
20K
$2.03
$40,690.00
78.75K
Nov 22
Form 4
+6.31%
3.49K
—
—
58.75K
Oct 1
Form 4
+3.33%
1.78K
—
—
55.27K
Jul 1
Form 4
+42.12%
15.85K
—
—
53.49K
Jun 15
Form 4/A
+3.57%
1.3K
—
—
37.63K
Apr 1
Form 4
+3.57%
1.3K
—
—
37.64K
Apr 1
Form 4/A
—
0
—
—
0
Form 4
+2.14%
761
—
—
36.34K
Jan 1
Form 4
—
0
—
—
0
Dec 23
Form 4
—
0
—
—
0
Sep 25
Form 4
+39.10%
10K
$2.22
$22,200.00
35.58K
Sep 7
Form 4
—
0
—
—
0
Jun 25
Form 4
+10.61%
36.8K
—
—
383.65K
Jun 23
Form 4
—
0
—
—
0
Jun 15
Form 4
+3.12%
10.49K
—
—
346.85K
Mar 25
Form 4
+31.21%
80K
—
—
336.36K
Jul 25
Form 4
—
0
—
—
0
Jun 23
Form 4
—
0
—
—
0
Mar 25
Form 4
+22.37%
46.86K
$1.73
-$57,337.39
256.36K
Jan 25 - Jan 26
Form 4
+41.59%
61.54K
—
—
209.5K
Oct 27
Form 4
—
0
—
—
0
Feb 15
Form 4
+0.34%
500
$10.00
$5,000.00
147.96K
Sep 4
Form 4
+0.68%
1K
$10.00
$10,000.00
147.46K
Aug 24 - Aug 27
Form 4
+17.39%
21.7K
$13.00
—
146.46K
May 30
Form 4
—
0
—
—
0
May 24
Form 3
—
0
—
—
0
No matching records found

Durata Therapeutics, Inc. No price found

Chief Medical Officer

Michael W. Dunne used to own units in Common Stock but no longer holds any shares there. In the year 2012 Michael W. Dunne filed a total of 5 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.22K
—
—
0
Nov 17
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
Feb 12
Form 4
∞
11.22K
—
—
11.22K
Mar 15 - Jul 24
Form 3
—
0
—
—
0
No matching records found